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Abstract  Transforaminal  injections  are  widely  used.  Serious  complications  including  strokes
and paraplegia  have  been  reported  after  transforaminal  injections  of  corticosteroids,  and  the
Afssaps (2011)  has  issued  a  warning  about  their  use  [1]. The  needle  must  be  positioned  in  the
posterior  aspect  of  foramen,  and  its  correct  placement  validated  by  an  injection  of  contrast
product.  It  is  preferable  to  choose  cortivazol  (Altim®)  as  the  corticoid  for  injection.  This  pro-
cedure is  simple,  reproducible,  and  durably  effective  in  60  to  70%  of  cases.  Complications  and
adverse effects  are  rare  but  potentially  serious:  allergies,  blood  pressure  surge,  vasovagal  syn-
cope, transient  exacerbation  of  pain,  infection,  stroke,  and  paraplegia.  The  aim  of  this  course
is to  stress  the  need  for  rigor  —– in  the  indication,  the  technical  performance  of  the  procedure,
and the  overall  management  of  the  patient.
© 2012  Éditions  françaises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Technique
In  2010,  ﬁve  radiologists  (DC,  SS,  LA,  ME,  and  VAB)  performed  1529  CT-guided  cervical
and  lumbar  transforaminal  injections  in  our  establishment  with  two  CT  scanners  (one  GE
Brightspeed  Elite  Advantage  16  - 2008  and  one  Brilliance  40  Philips  -  2006).  The  injection
was  cervical  in  24.4%  of  the  cases,  lumbar  in  75.6%.
The  physicians  referring  these  patients  were  rheumatologists  in  51%  of  the  cases,
general  practitioners  in  40%,  neurosurgeons  and  orthopedic  surgeons  in  8%,  and,  more
rarely,  neurologists.  Systematically,  all  patients  who  were  referred  for  a  cervical  or  lum-
bar  injection  procedure  of  any  type,  received  with  their  appointment  a  letter  (Appendix
I)  explaining  the  procedure,  the  contraindications,  and  incompatibility  with  some  drugs,
∗ Corresponding author.
E-mail address: claude.depriester@yahoo.com (C. Depriester).
211-5684/$ — see front matter © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
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the  lumbar  region.  We  do  not  inject  Xylocaine® into  the  cer-
vical  spine  because  of  the  proximity  of  the  vertebral  artery.
No  procedures  are  performed  under  sedation  so  that  weCT-guided  transforaminal  cervical  and  lumbar  epidural  injec
in  particular  anti-coagulants  and  platelet  aggregation
inhibitors.  They  also  received  an  informed  consent  form
(Appendix  II).  When  appointments  were  made  directly  by
the  patients,  as  they  often  were,  our  trained  secretaries
also  provided  this  information  by  telephone.
The  day  of  the  procedure:  the  patient  brings  his  or  her
ﬁle  with  him;  if  not,  the  procedure  is  postponed.
The  radiologist:
• sees  the  patient,  questions  him  about  his  clinical  symp-
toms,  the  different  treatments  already  undertaken  —–
manipulations,  medications,  physical  therapy,  injections,
surgery,  etc.;
• veriﬁes  that  the  patient’s  current  condition  presents  no
contraindications  to  the  procedure:
◦ platelet  aggregation  inhibitor  or  anti-coagulant  treat-
ment  that  was  not  stopped  either  at  all  or  for  a  long
enough  period,
◦ is  the  pain  still  present?  It  is  not  unusual  for  patients,
while  awaiting  this  appointment,  to  ﬁnd  their  pain
relieved  by  rest,  sick  leave,  medical  treatment,  etc.
In  this  case,  we  do  not  perform  the  injection,
◦ does  he  have  an  intercurrent  infectious  condition  —–
general,  bronchial,  cutaneous,  urinary  or  other?  If  so,
the  procedure  is  postponed  to  a  later  date  to  avoid  any
infectious  complications,
◦ does  he  have  any  drug  or  other  known  allergies?
◦ does  he  have  diabetes?  If  so,  he  is  instructed  to  moni-
tor  his  blood  glucose  very  strictly  for  the  week  to  come,
and  this  is  mentioned  on  the  report  to  the  general  prac-
titioner;
• examines  the  radiology  ﬁle,  which  must  include:
◦ standard  radiographs  to  screen  for  a  potential  tran-
sitional  abnormality,  subluxation  in  standing  position,
etc.,
◦ a  CT  scan,
◦ or MRI,  with  injection  of  contrast  product  if  necessary
in  patients  with  a  history  of  surgery,
◦ any  laboratory  results  with  examination  of  hemostatic
variables  if  the  patient  is  under  long-term  treatment
with  platelet  aggregation  inhibitors,
◦ if no  slice  imaging  was  previously  performed,  we  do
so  before  the  procedure,  and  we  obviously  discuss  the
indications  for  the  procedure.
One  or  more  skilled  radiology  technicians  place  the
patient  on  the  apparatus  and  explain  the  procedure  to  him
to  help  him  relax.  The  radiologist  chooses  the  segment  for
the  injection  and  informs  the  technician.
At what segment should the injection be
performed?
In  the  cervical  spine,  the  injection  should  go  into  the
segment  involved.  For  example,  cervicobrachial  neuralgia
(CBN)  involving  the  right  side  of  C6  is  injected  at  the  right
C5-C6  foramen.  In  the  lumbar  region,  it  depends  on  the  site
of  the  impingement;  if  it  is  foraminal  or  extraforaminal,  the
foramen  is  targeted;  on  the  other  hand  if  it  is  a  postero-
lateral  discoradicular  impingement,  the  foramen  below  is
injected,  to  facilitate  contact  with  the  spinal  ganglion  of
the  corresponding  root:  injection  for  left  L5  sciatica  from  a
left  L4-L5  posterolateral  herniated  disc  is  through  the  left
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5-S1  foramen.  In  the  cervical  region,  contrast  product  is
njected  intravenously  to  locate  the  vascular  structures;  this
recaution  is  not  necessary  for  the  lumbar  region.  Helical
cquisition  is  then  centered  on  the  involved  segment,  and
our  slices  are  positioned.
For  the  transforaminal  cervical  routes,  the  approach  is
nterolateral  and  the  patient  in  the  dorsal  decubitus  posi-
ion;  for  transforaminal  lumbar  routes,  the  approach  is
osterolateral  and  the  patient  position  ventral  decubitus.
nce  the  injection  path  has  been  identiﬁed,  it  is  labeled
n  the  skin.  The  technician  then  cleans  the  skin  a  ﬁrst  time
ith  an  antiseptic  solution.  The  technician  prepares  a  sterile
able  with  all  the  necessary  equipment.  We  use  a  Chiba  short
evel  needle  —– 22G.  It  should  not  be  any  thinner  because
hat  would  increase  the  theoretical  risk  of  catheterization
r  vascular  trauma  [2—4]. The  skin  is  cleaned  a  second  time,
his  time  by  the  radiologist,  who  coats  a sterile  ﬁeld.  Then
he  patient  is  told  that  the  puncture  is  beginning,  and  the
eedle  is  positioned  in  the  posterior  and  external  part  of  the
oramen,  immediately  behind  the  spinal  ganglion  (Fig.  1).
e  aspirate  for  8  to  10  seconds  to  verify  the  absence  of  blood
eﬂux,  although  this  absence  does  not  guarantee  that  there
s  no  vascular  invasion  [5—7]. Contrast  product  (Iodixanol,
isipaque  270)  is  injected  (0.3  to  0.5  cc)  slowly  under  clin-
cal  and  CT-guidance  (Fig.  2).  If  vascular  opaciﬁcation  or  a
‘washout’’  effect  is  observed,  that  is,  if  no  opaciﬁcation  of
he  foramen  is  seen,  the  opaciﬁcation  is  very  probably  arte-
ial;  the  needle  must  then  be  repositioned,  contrast  product
njected  again,  and  the  opaciﬁcation  veriﬁed.
Foraminal  diffusion  can  appear  lump-like.  Leakage  into
he  epidural  space  is  often  observed.
In  no  case  do  we  force  catheterization  of  the  foramen:
he  injection  is  periganglionic  and  not  preganglionic.  To
ptimize  radioprotection,  we  minimize  the  irradiation  con-
tants,  but  can  still  follow  the  trajectory  of  the  needle  and
he  opaciﬁcation  of  the  foramen.  The  mean  irradiation  for
atients  is  61  cGy  cm2 in  the  cervical  spine  and  74  cGy  cm2
n  the  lumbar  spine.
One  to  2  cc  of  lidocaine  hydrochlorate  (Xylocaine®
0  mg/mL  without  preservatives)  is  injected  very  slowly  intoigure 1. Placement of the needle at the foramen entrance. 1:
eedle; 2: aorta; 3: radicular medullary artery; 4: spinal ganglion;
: dural sac.
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•igure 2. Transforaminal injections, C5-C6 right; a: slice through
he needle in the posterior external aspect of the foramen; d: inje
an  examine  the  patient,  communicate  with  him  and  detect
ny  complications  or  adverse  effects  as  rapidly  as  possi-
le.  Then,  2  or  3  minutes  after  the  lidocaine,  very  slowly,
o  avoid  producing  excessive  pressure  on  the  needle  and
otentially  forcing  it  into  a  vascular  vessel,  we  inject  an
mpoule  of  cortivazol  (Altim®);  we  do  not  use  acetate  of
rednisolone  (Hydrocortancyl®)  because  its  presentation  is
ubstantially  larger  (5  cc  versus  1.5  cc),  and  it  is  known  to
orm  macroaggregates  that  can  cause  distal  vascular  emboli
8—11].  The  puncture  needle  is  then  withdrawn  and  a  local
andage  placed,  which  the  patient  removes  the  following
orning.
The  pain  is  often  reactivated  in  the  lumbar  region  (two
hirds  of  cases),  whether  the  cause  of  the  root  compression
s  osteoarthritic  or  discal.  Pain  reactivation  is  rarer  in  the
ervical  region,  probably  because  we  do  not  use  lidocaine
here.  Patients  remain  under  observation  in  the  CT  prepa-
ation  room  for  30  to  60  minutes,  in  armchairs  after  cervical
rocedures  and  on  stretchers  after  lumbar  injections.  We
ecommend  that  someone  come  with  them  and  especially
hat  they  not  drive  themselves  home.  We  also  advise  them
o  rest  for  24  to  48  hours  and  to  see  the  physician  who  pre-
cribed  the  procedure  within  2  to  4  weeks.  As  part  of  the
ontinuity  of  care,  we  are  of  course  at  their  disposition  to
ee  them  in  case  of  any  problem,  and  can  be  contacted
y  a  telephone  hotline.  All  percutaneous  procedures  are
erformed  on  an  outpatient  basis,  but  in  a  healthcare  facil-
ty  with  anesthetists/critical-care  specialists,  cardiologists,
•
•oramen; b: pinpointing location for the approach; c: placement of
 of contrast product and its lump-like diffusion.
tc.,  available  onsite.  The  CT  room  contains  resuscitation
quipment  that  is  checked  regularly.
hat are the indications for
T-guided  transforaminal injections?
adicular  pain,  related  to  disc  impingement  or  osteoarthritic
tenosis  of  the  foramen  or  the  lateral  recess,  is  the  indica-
ion  for  this  type  of  injection.  It  must  not  be  a  ﬁrst-line
reatment;  it  should  only  be  performed  after  appropriate
edical  treatment,  including  rest  and  oral  medication  for  3
o  4  weeks.  In  21%  of  cases,  a  second  procedure  was  per-
ormed  soon  after  the  ﬁrst  (4  to  6  weeks  later).  In  19%  of
ases,  the  patient  had  already  had  spinal  surgery,  on  the
ame  or  an  adjacent  segment.
hat is the mechanism of action of these local
nti-inﬂammatory agents? [12,13]
adicular  pain  is  related  to  several  factors:
mechanical,  of  course,  by  compression  linked  to  a  herni-
ated  disc  or  osteoarthritic  stenosis;
this  compression  engenders  a  molecular  reaction  with  the
release  of  disc  decay  products  (prostaglandin  and  phos-
pholipase  A2);
inﬂammatory  reaction  (response  to  the  decay  products);
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• vascular  reaction  to  venous  congestion  in  the  foramen
and  edematous  reaction  through  the  increase  in  vascular
permeability.
Anti-inﬂammatories  can  act  locally,  directly  on  the
inﬂammation  factors.
Complications recorded in our series
• three  blood  pressure  surges  (0.2%):  all  three  cases
involved  patients  under  treatment  for  hypertension
(two  lumbar  injections  and  one  cervical).  This  surge
occurred  immediately  after  the  procedure  in  one  case  and
15  minutes  afterwards  in  the  other  two.  It  was  accom-
panied  by  a  sensation  of  malaise,  with  headache;  blood
pressure  soared  above  210/160.  Venous  access  was  placed
for  the  lumbar  procedures  and  kept  for  the  cervical  one;
pulse,  blood  pressure,  and  ECG  monitoring  began  in  the
preparation  room,  and  the  on-call  cardiologist  was  called
immediately  for  management  in  the  intensive  care  unit.
One  patient  was  hospitalized  for  24  hours;  the  other  two
were  allowed  to  return  home  after  several  hours  of  obser-
vation  and  were  advised  to  see  their  general  practitioner
and/or  their  cardiologist  to  verify  their  blood  pressure
later;
• thirty-ﬁve  vasovagal  syncopes  (2.3%),  all  spontaneously
resolved  after  leg  elevation.  In  three  cases,  it  occurred
before  the  procedure,  during  the  establishment  of
brachial  venous  access,  before  the  percutaneous  cervical
procedure;
• ﬁve  cases  of  allergic  reactions  (0.3%)  occurred,  with  dys-
pnea  and  facial  erythema;  all  resolved  rapidly  after  an
IV  injection  of  200  mg  of  hydrocortisone  hemisuccinate.
Patients  with  a  history  of  allergies  were  premedicated
according  to  standard  procedures  before  we  began.  In
cases  of  known  allergies  to  iodinated  contrast  product,
we  do  not  inject  it  before  the  steroid  injection.  In  these
cases,  the  aspiration  maneuvers  are  longer  and  the  pro-
cedure  must  be  performed  with  CT  and  not  ﬂuoroscopy;
• reproduction  of  the  pain  during  the  procedure  must  not
be  considered  a  complication:  it  is  very  frequent  (65%)
in  the  lumbar  region,  sometimes  accompanied  by  the
onset  of  paresthesia  secondary  to  the  injection  proce-
dure;  this  resolves  in  a  period  between  several  minutes
and  a  half-hour.  We  routinely  keep  the  patients  lying
down  on  a  stretcher.  Should  these  very  frequent  episodes
of  paresthesia  lead  us  to  omit  the  Xylocaine® injection
that  precedes  the  Altim® injection,  as  we  do  in  the
cervical  spine?  This  injection  can  be  recommended  as  a
test-dose  before  that  of  the  corticosteroid  to  observe  a
potential  neurological  complication  that  would  be  only
transient  after  lidocaine  [14];
• an  increase  in  radicular  pain  in  the  days  following  the
injection  is  fairly  frequent,  reported  in  37.4%  of  the  cases
in  Huston’s  series  [15], especially  in  the  cervical  injec-
tions.  We  have  made  similar  observations.
Should interlaminar injections be performed
more often?
In  the  cervical  region,  interlaminar  procedures  are  more
difﬁcult  for  patients,  and  complications  including  subdural
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ematomas  or  direct  puncture  of  the  spinal  cord  have  been
escribed  [16,17].  They  are  sometimes  performed  under
edation  [18]; the  risk  of  missing  an  acute  complication  is
hen  much  greater.  At  the  lumbar  level,  the  procedure  is
imple;  it  is  often  less  painful  than  a  transforaminal  pro-
edure  because  it  does  not  cause  transient  exacerbation  of
he  radicular  pain.  Nonetheless,  in  cases  of  postoperative
ain,  the  placement  of  the  needle  can  also  be  dangerous
ecause  of  post-laminectomy  remodeling,  with  a  risk  of
pidural  hyperemia  and  therefore  of  increased  vascular  pas-
age  of  the  corticoid  [19]. The  complications  may  be  delayed
ecause  of  the  puncture  site  (epidural  hematoma).  When
adicular  impingement  is  the  cause  of  the  pain,  the  forami-
al  site  of  the  injection  procedure  is  logical:  corticosteroids
re  injected  at  the  very  seat  of  the  radicular  impingement.
n  the  other  hand,  when  the  patient  complains  of  lumbo-
ruro-sciatalgia  or  alternating  sciatica,  a  posterior  epidural
njection  is  probably  more  logical.  The  technique  must  also
e  extremely  rigorous.
hould the transforaminal injections be
erformed under videoﬂuoroscopy with
igital subtraction angiography?
rterial  passage  of  contrast  product  is  probably  best  iden-
iﬁed  by  ﬂuoroscopy  or  during  an  angiographic  series,  but
nly  for  expert  eyes,  experienced  in  angiography.  These
rteriographies  have  been  almost  totally  replaced  by  CT-
ngiography  or  MRI-angiography,  however,  and  this  change
akes  it  more  difﬁcult  to  train  young  radiologists.  More-
ver,  the  simplicity  of  needle  placement  under  CT-guidance
s  such  that  it  is  probably  fairly  easy  to  learn  to  perform
his  technique  rigorously  to  avoid  the  error  of  vascular  and
specially  arterial  introduction  of  the  product.
hat other complications have been observed
nd reported in the literature?
ybier  has  collected  several  cases  of  dramatic
omplications,  recently  observed  and  reported  in  the
iterature.  These  led  to  the  Afssaps  warning  issued  in  March
011  [1,8—11,14,16].
Twelve  dramatic  complications  with  strokes  or  para-  or
etraplegia  have  been  reported,  none  with  Altim®.  These
omplications  are  probably  linked  to  arterial  emboli,  due
n  turn  to  particulate  injections.  The  size  of  the  particles
epends  on  the  corticoid  injected  [20], soluble  in  aqueous
edia  (Altim®)  or  non-soluble,  in  a  microcrystalline  suspen-
ion  with  a  tendency  to  clump  (Hydrocortancyl®).
The  molecules  that  transport  glucocorticosteroids  can
lso  be  toxic  (benzyl  alcohol,  polyethylene  glycol)  [21]. A
irect  breach  of  a  branch  of  the  radiculomedullary  artery
y  the  needle  in  the  foramen  can  lead  to  a  spasm  or  cause
n  embolism  and  an  infarction.
These  arterial  complications  are  linked  to  the  anatomy
f  the  foramen  and  the  vascularization  of  the  spinal  cord
y  the  anterior  spinal  axis  (ASA),  which  is  fed  by  the  ante-
ior  radiculomedullary  arteries.  The  largest  of  these  is  the
damkiewicz  artery,  which  vascularizes  the  thoracic  spinal
ord  and  the  terminal  cone.  It  arises  most  often  on  the  left,
rom  an  intercostal  branch  but  it  can  also  develop  on  the
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essential  to  stress  both  the  need  for  rigor  in  the  performance08  
ight  or  from  a  lumbar  or  even  sacral  branch.  Another  large
rterial  branch  begins  in  C5  or  C6  and  provides  blood  to  the
ervical  enlargement.  The  arterial  branches  penetrate  the
oramen  and  the  dura  mater  along  the  entire  path  where
he  nerves  emerge;  these  arteries  then  divide  into  dural
ranches.  There  are  also  posterior  spinal  arteries,  which  are
ery  variable,  less  systematized,  and  much  thinner.
There  is  thus  a  great  anatomical  variability  in  the  source
f  the  arteries  feeding  the  spinal  cord.  Normally,  radicular
rteries  enter  the  anterior  part  of  the  foramen,  medial  to
he  spinal  ganglion.  Nonetheless,  a  recent  study  by  Huntoon
f  dissections  of  the  cervical  spine  [22]  shows  that  the
ranches  of  the  deep  and  ascending  cervical  arteries  could
nter  the  foramen  in  its  posterior  aspect,  which  is  the  target
or  the  injection.  These  branches  can  participate  in  spinal
ord  vascularization.  Moreover,  in  the  case  of  osteoarthritic
r  postoperative  remodeling,  these  anatomical  relations
ay  change.  Both  these  facts  demonstrate  the  complex-
ty  and  variability  of  arterial  positions  in  the  intervertebral
oramen.
Venous  structures  are  also  present,  more  or  less  dilated,
ocated  outside  the  spinal  ganglion.  Their  distribution  has
reviously  been  studied  by  lumbar  phlebography,  which
howed  epidural  lumbosacral  venous  plexuses,  pushed  back
y  hernias  or  dilated  upstream  of  a  stenosis  [5].  The  epidu-
al  veins  are  also  complex  and  connected  with  spinal  cord
eins  [23]. According  to  Candido,  the  use  of  speciﬁc  needles,
ith  curved  tips  or  a  lateral  oriﬁce,  does  not  seem  to  pre-
ent  the  intravascular  passage  of  products  effectively  [4].
n  the  other  hand,  Scanlon  et  al.  recommends  using  these
peciﬁc  needles  [24].
What  needles  should  be  utilized?  Not  thinner  than  22G,
hat  is,  approximately  400    in  diameter.
Aspiration  by  the  needle  before  any  injection  of  corti-
oids  or  Xylocaine® does  not  sufﬁce  to  avoid  intravascular
njection  [5—7]. Other  complications  have  been  docu-
ented:
one  case  of  epidural  hematoma  has  been  described
after  transforaminal  injections  [16]. The  hematoma  may
be  linked  to  venous  bleeding;  the  clinical  symptoms
appeared  several  days  after  the  procedure.  The  authors
reported  that  injection  of  contrast  into  the  epidural
venous  plexus  is  probably  more  difﬁcult  to  authen-
ticate  than  intra-arterial  passage,  thus  pointing  out
the  importance  of  good  image  quality.  This  complica-
tion  occurs  more  commonly  after  interlaminar  epidural
injections;
headaches  were  described;  they  are  very  rare  in  trans-
foraminal  injections  and  more  frequent  in  epidural
procedures.  In  this  case,  they  are  a  sign  of  an  unnoticed
meningeal  breach.  They  most  often  resolve  spontaneously
in  several  days.  When  they  persist,  a  blood  patch  must  be
placed;
infectious  complications  are  always  a  threat.  They  have
been  described  in  transforaminal,  epidural,  and  inter-
facet  injections.  Nonetheless,  no  published  series  exists.
Spondylodiscitis,  meningitis,  and  epidural  abscesses  have
been  reported.  These  complications  are  extremely  rare
[25,26].  In  a  review  of  complications  of  injections  by
rheumatologists  published  by  Barden  in  2002,  the  rate  of
infectious  complications  was  determined  to  be  1/77,300
cases  [27];
o
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metabolic disorders,  especially,  blood  glucose.  Strict
monitoring  of  blood  glucose  should  be  recommended  to
patients  with  diabetes.
iscussion
omplications  are  very  rare  in  both  transforaminal  and  inter-
aminar  injections  and  are  essentially  the  same  in  both
roups  [19]. The  technique  must  be  meticulous,  rigorous,
nd  reproducible.  The  ﬁles  must  be  examined  and  the  clini-
al  appropriateness  of  the  planned  procedure  veriﬁed.  The
eedle  must  be  placed  very  precisely,  under  either  CT  or  ﬂu-
roscopic  guidance,  with  contrast  product  injected  to  assess
he  diffusion  space.  Only  then  should  the  corticoid,  which
ust  be  cortivazol,  be  slowly  injected.  Compliance  with  all
f  these  requirements  should  limit  the  complications.
This  procedure  involves  teamwork  with  radiology  techni-
ians,  who  must  be  trained  very  speciﬁcally  and  in  detail,  as
or  all  interventional  procedures.  Always  bear  in  mind  the
reat  variability  in  foraminal,  dural,  epidural  and  medullary
ascularization  and  the  possibility  of  postoperative  changes
r  venous  engorgement  in  stenotic  foramina.  Nonetheless,
ero  risk  does  not  exist.  Schaufele  [19]  estimated  that  the
isk  of  a  dramatic  complication  following  a transforaminal
orticoid  injection  ranges  from  1/100,000  to  1/1,000,000.
ut  these  are  only  statistics.
The  alternative  of  interlaminar  injections  also  carries
dditional  risks,  including  epidural  hematomas  or  direct
rauma  to  the  spinal  cord.  Moreover,  it  may  be  equally
nappropriate  to  recommend  this  interlaminar  approach  to
atients  with  previous  spinal  surgery,  given  that  postoper-
tive  ligament  and  epidural  remodeling  can  promote  the
nset  of  complications  [11]. Nor  is  the  interlaminar  injec-
ion  as  effective  for  radicular  pain  as  the  transforaminal
rocedure  [28]. Some  authors  recommend  posterior  articu-
ar  approaches  for  the  cervical  spine  and  epidural  for  lumbar
nd  only  for  spines  which  have  had  no  surgery  [29]. This  is
herefore  very  reductive,  especially  since  these  are  often
oung  or  working  patients  who  have  already  had  several
reatments  that  did  not  help  (oral  and  injectable  medica-
ion,  physical,  physical  therapy,  etc.).  Efﬁcacy  has  been
emonstrated  at  both  the  cervical  and  lumbar  levels:  65  to
0%  of  patients  report  durable  pain  relief  (mean  duration  15
onths)  with  improvement  at  the  end  of  13  days,  on  aver-
ge  [13,30]. Several  simple  rules  should  be  borne  in  mind  to
inimize  the  risks  [14]:
never  perform  these  procedures  under  sedation;
place  the  tip  of  the  needle  in  the  posterior  aspect  of  the
foramen;
inject  contrast  product;
for  lumbar  procedures,  inject  a  test  dose  of  lidocaine  and
wait  2  or  3  minutes  before  injecting  cortivazol.
onclusion
he  use  of  these  types  of  injections  must  continue,  but  it  isf  this  procedure  and  the  importance  of  the  training  of  inter-
entional  radiologists  specializing  in  the  spine  to  standardize
ractices  and  minimize  risks.  Both  the  physicians  prescribing
tion
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these  procedures  and  those  performing  them  must  be  per-
fectly  aware  of  all  of  these  risks.  The  patient  must  also  be
informed  about  the  technique,  the  risks  involved  and  the
estimated  success  rate  of  65  to  70%,  as  well  as  of  the  need
to  rest  for  24  to  48  hours  after  the  procedure  [13,30].
TAKE-HOME  MESSAGES
• Rigor  in  the  examination  of  the  patient  and  the  ﬁle
and  in  performing  the  procedure.
• Performance  of  the  procedure  in  a  healthcare
facility.
• Important  role  of  the  radiology  technician  in  patient
placement  and  in  pinpointing  locations.
• Standardized  training  in  interventional  radiology.
• Know  all  the  potential  risks.
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Madam,  Sir:
You  are  expected
at.............
on  the  .  .  .. .  .. .  .. .  .. .  .. .  .  for  a
radiology  examination.
So  that  it  can  take  place  in  the  best  possible
conditions,  we  ask  you  to  follow  the  instructions
below:
For  the  examination,
-  Bring  with  you  the  product  prescribed  on  the
attached  prescriptions  or  prescribed  by  the
rheumatologist  or  your  general  practitioner.
-  If  you  currently  take  the  following  medication:
•  TICLID,  PLAVIX:  contact  us  at  .  .  .
•  KARDEGIC:  stop  this  treatment  one  week
before  the  examination;  contact  your  general
practitioner  for  a  temporary  replacement.
•  PREVISCAN,  SINTROM:  stop  this  treatment  4
days  before  the  examination;  contact  your  general
practitioner  for  a  temporary  replacement.•  HEPARIN,  CALCIPARIN,  FRAXIPARIN:  perform
the  last  injection  at  least  12  hours  before  the
examination.
i
b
cs  709
 Bring  with  you  all  documents  concerning
xamination,  images  from  radiography,  CT,  MRI.  .  ..
 Plan  to  have  someone  accompany  you  who  knows
ow  to  drive  (possible  pain).
 If  you  are  or  think  you  might  be  pregnant,  please
et  us  know.
The  Secretariat  of  Radiology
ppendix II. Informational letter before
pinal corticoid injection under CT or
uoroscopic guidance
adam,  Sir:
Your  physician  has  prescribed  a  spinal  injection  to  treat
ervicobrachial  neuralgia  or  sciatica  due  to  impingement  in
he  vertebral  column  or  low  back  pain.
This  injection  is  often  effective  in  relieving  this  pain.
onetheless  it  may  involve  some  complications  that  you
ust  be  informed  about:
 Bleeding  complications  (hematoma);  thus  the  examination
cannot  be  performed  if  you  are  taking  an  anti-coagulant
treatment  or  platelet  aggregation  inhibitor  (ASPIRIN,
PLAVIX).  These  treatments  (except  for  posterior  articular
and  sacroiliac  injections)  must  be  stopped  several  days
before  the  procedure,  possibly  replaced  temporarily  by
injections  of  low-molecular-weight  heparin,  depending  on
the  case  (to  see  with  your  general  practitioner);
 Infectious  complications  (abscesses);
 Allergy  to  iodine,  because  as  a  general  rule  we  inject  an
iodinated  contrast  product  before  the  main  injection  to
verify  that  the  corticosteroid  is  not  being  injected  in  a
blood  vessel.
Most  often,  this  would  be  a  simple  urticaria  (hives),  but
ore  serious  allergic  accidents  (asthma,  giant  urticaria,  and
naphylactic  shock)  have  been  observed,  fortunately  very
arely.
Please  tell  us  if  you  have  a  history  of  allergy  to  iodine
r  of  severe  allergies  to  other  substances;  anti-allergic  pre-
edication  for  three  days  might  be  necessary,  depending  on
he  situation:
 Complication  associated  with  the  metabolic  activity  of
injectable  corticosteroids  and,  in  particular,  loss  of  dia-
betes  control;
 You  must  also  be  informed  of  the  very  rare  risk  of  a  neu-
rological  accident  after  transforaminal  injections:
◦  Tetraplegia  (paralysis  of  four  limbs)  after  cervical  injec-
tion,
◦ Paraplegia  (two  lower  limbs)  after  lumbar  injection,
◦ Cerebrovascular  accident  (stroke).
These  accidents  are  extremely  unusual  (several  cases
escribed  in  the  literature,  and  not  with  the  corticoid  that
e  use).
After  the  injection:
You  are  advised  to  rest  for  24—48  h.
It  is  possible  to  perceive  unusual  pain  in  the  back,  arm  or
n  leg  in  the  days  after  the  injection;  it  is  probably  caused
y  the  injected  corticoid,  a  suspension  that  contains  small
rystals  that  can  trigger  an  inﬂammatory  attack.  In  this  case,
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he  pain  will  disappear  progressively  over  several  days;  it
hould  be  controlled  by  an  ice  bag  and  minor  analgesics
DOLIPRAN).
On  the  other  hand,  please  contact  us  if  this  pain  persists
or  more  than  a  week  without  diminishing,  if  it  increases
rogressively  after  a  week,  or  if  you  have  a  fever:  we  will
rrange  to  see  you  to  look  for  a  rare  infection  associated
ith  the  puncture.  Attention,  do  not  confuse  this  unusual
ain  caused  by  the  corticoid  with  the  pain  for  which  we
re  performing  the  injection!  That  can  persist  longer  than
ne  week  without  being  abnormal.  Sometimes  it  may  take  2
o  3  weeks  before  observing  improvement  in  the  pain  after
njection.
We  are  at  your  disposition  for  any  additional  information.
,
onsent  to  the  performance  of  a  spinal  injection.
Date:
Signature:
Please  bring  this  sheet,  signed,  with  you  to  your  appoint-
ent,  together  with  your  radiology  ﬁles  and  your  physician’s
rescription.
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